ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Erythropoietin Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
Published Date: June 2025
|
Report Code: QYRE-Auto-33I11993
Home | Market Reports | Science| Biological Sciences
Global Erythropoietin Market Size Manufacturers Supply Chain Sales Channel and Clients 2022 2028
BUY CHAPTERS

Global Erythropoietin Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Code: QYRE-Auto-33I11993
Report
June 2025
Pages:136
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Amgen Inc
Johnson & Johnson
Roche
Galenica Ltd
Emcure
Kyowa Hakko Kirin
3SBio Inc
Biocon Ltd.
LG Life Sciences

Erythropoietin Market Size

In 2024, the global market size of Erythropoietin was estimated to be worth US$ 10240 million and is forecast to reach approximately US$ 15110 million by 2031 with a CAGR of 5.8% during the forecast period 2025-2031.

Erythropoietin Market

Erythropoietin Market

Erythropoietin is produced by interstitial fibroblasts in the kidney in close association with peritubular capillary and proximal convoluted tubule. It is also produced in perisinusoidal cells in the liver. While liver production predominates in the fetal and perinatal period, renal production is predominant during adulthood.
Erythropoietin is an essential hormone for red blood cell production. Without it, definitive erythropoiesis does not take place. Under hypoxic conditions, the kidney will produce and secrete erythropoietin to increase the production of red blood cells by targeting CFU-E, proerythroblast and basophilic erythroblast subsets in the differentiation. Erythropoietin has its primary effect on red blood cell progenitors and precursors (which are found in the bone marrow in humans) by promoting their survival through protecting these cells from apoptosis, or cell death.
In this report, we definite one unit for 1ml, except Epoetin-alfa type, which one unit means 10000units/ml
The major players in global Erythropoietin market include Amgen, Johnson & Johnson, etc. The top 2 players occupy about 60% shares of the global market. North America is the main market, and occupies over 65% of the global market. Epoetin-alfa is the main type, with a share about 80%. Kidney Disorders is the key application, which holds a share over 40%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Erythropoietin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Erythropoietin.
The Erythropoietin market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Erythropoietin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Erythropoietin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.

Scope of Erythropoietin Market Report

Report Metric Details
Report Name Erythropoietin Market
CAGR 5.8%
Segment by Type
  • Epoetin-alfa
  • Epoetin-beta
  • Darbepoetin-alfa
  • Others
Segment by Application
  • Anemia
  • Kidney Disorders
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Amgen, Johnson & Johnson, Roche, Galenica, Emcure, Kyowa Hakko Kirin, 3SBio, Biocon, LG Life Sciences
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Erythropoietin in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
  • Chapter 3: Detailed analysis of Erythropoietin manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Erythropoietin sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: Research Findings and Conclusion.

FAQ for this report

What is the market share of major companies in Erythropoietin Market?

Ans: The top 2 players occupy about 60% shares of the global market.

What is the Erythropoietin Market share by region?

Ans: North America is the main market, and occupies over 65% of the global market.

What is the Erythropoietin Market share by type?

Ans: Epoetin-alfa is the main type, with a share about 80%.

What is the Erythropoietin Market share by application?

Ans: Kidney Disorders is the key application, which holds a share over 40%.

Who are the main players in the Erythropoietin Market report?

Ans: The main players in the Erythropoietin Market are Amgen, Johnson & Johnson, Roche, Galenica, Emcure, Kyowa Hakko Kirin, 3SBio, Biocon, LG Life Sciences

What are the Application segmentation covered in the Erythropoietin Market report?

Ans: The Applications covered in the Erythropoietin Market report are Anemia, Kidney Disorders, Others

What are the Type segmentation covered in the Erythropoietin Market report?

Ans: The Types covered in the Erythropoietin Market report are Epoetin-alfa, Epoetin-beta, Darbepoetin-alfa, Others

Recommended Reports

Erythropoietin Markets

Anemia Related Markets

Blood & Kidney Devices

1 Study Coverage
1.1 Erythropoietin Product Introduction
1.2 Market by Type
1.2.1 Global Erythropoietin Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Epoetin-alfa
1.2.3 Epoetin-beta
1.2.4 Darbepoetin-alfa
1.2.5 Others
1.3 Market by Application
1.3.1 Global Erythropoietin Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Anemia
1.3.3 Kidney Disorders
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Erythropoietin Market Size Estimates and Forecasts
2.1.1 Global Erythropoietin Revenue 2020-2031
2.1.2 Global Erythropoietin Sales 2020-2031
2.2 Erythropoietin Market Size by Region: 2024 Versus 2031
2.3 Erythropoietin Sales by Region (2020-2031)
2.3.1 Global Erythropoietin Sales by Region: 2020-2025
2.3.2 Global Erythropoietin Sales Forecast by Region (2026-2031)
2.3.3 Global Erythropoietin Sales Market Share by Region (2020-2031)
2.4 Erythropoietin Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Erythropoietin Revenue by Region: 2020-2025
2.4.2 Global Erythropoietin Revenue Forecast by Region (2026-2031)
2.4.3 Global Erythropoietin Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Erythropoietin Sales by Type (2020-2031)
3.1.1.1 Global Erythropoietin Sales Volume by Type (2020-2031)
3.1.1.2 Global Erythropoietin Sales Market Share by Type (2020-2031)
3.1.2 Global Erythropoietin Revenue by Type (2020-2031)
3.1.2.1 Global Erythropoietin Revenue by Type (2020-2031)
3.1.2.2 Global Erythropoietin Revenue Market Share by Type (2020-2031)
3.1.3 Erythropoietin Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Erythropoietin Sales by Application (2020-2031)
3.2.1.1 Global Erythropoietin Sales Volume by Application (2020-2031)
3.2.1.2 Global Erythropoietin Sales Market Share by Application (2020-2031)
3.2.2 Global Erythropoietin Revenue by Application (2020-2031)
3.2.2.1 Global Erythropoietin Revenue by Application (2020-2031)
3.2.2.2 Global Erythropoietin Revenue Market Share by Application (2020-2031)
3.2.3 Erythropoietin Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Epoetin-alfa of Erythropoietin Revenue Market Share by Application
3.3.2 Epoetin-beta of Erythropoietin Revenue Market Share by Application
3.3.3 Darbepoetin-alfa of Erythropoietin Revenue Market Share by Application
3.3.4 Others of Erythropoietin Revenue Market Share by Application
4 Global Erythropoietin by Manufacturers
4.1 Global Top Erythropoietin Manufacturers by Sales (2020-2025)
4.1.1 Global Erythropoietin Sales by Manufacturer (2020-2025)
4.1.2 Global Erythropoietin Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Erythropoietin Manufacturers by Revenue (2020-2025)
4.2.1 Global Erythropoietin Revenue by Manufacturer (2020-2025)
4.2.2 Global Erythropoietin Revenue Share by Manufacturer (2020-2025)
4.3 Global Erythropoietin Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Erythropoietin Manufacturers Covered: Ranking by Revenue
4.4.2 Global Erythropoietin Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Erythropoietin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Erythropoietin Manufacturing Base Distribution, Product Type
4.5.1 Erythropoietin Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Erythropoietin Market
4.5.3 Manufacturers Erythropoietin Product Type and Application
4.5.4 Epoetin-alfa Market Sales of Erythropoietin by Manufacturer
4.5.5 Epoetin-beta Market Sales of Erythropoietin by Manufacturer
4.5.6 Darbepoetin-alfa Market Sales of Erythropoietin by Manufacturer
4.5.7 Others Market Sales of Erythropoietin by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Amgen
5.1.1 Amgen Company Information
5.1.2 Amgen Description, Business Overview
5.1.3 Amgen Erythropoietin Products Offered
5.1.4 Amgen Erythropoietin Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Amgen Erythropoietin Sales by Product in 2024
5.1.6 Amgen Erythropoietin Sales by Application in 2024
5.1.7 Amgen Erythropoietin Sales by Geographic Area in 2024
5.1.8 Amgen Recent Developments
5.2 Johnson & Johnson
5.2.1 Johnson & Johnson Company Information
5.2.2 Johnson & Johnson Description, Business Overview
5.2.3 Johnson & Johnson Erythropoietin Products Offered
5.2.4 Johnson & Johnson Erythropoietin Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Johnson & Johnson Erythropoietin Sales by Product in 2024
5.2.6 Johnson & Johnson Erythropoietin Sales by Application in 2024
5.2.7 Johnson & Johnson Erythropoietin Sales by Geographic Area in 2024
5.2.8 Johnson & Johnson Recent Developments
5.3 Roche
5.3.1 Roche Company Information
5.3.2 Roche Description, Business Overview
5.3.3 Roche Erythropoietin Products Offered
5.3.4 Roche Erythropoietin Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Roche Erythropoietin Sales by Product in 2024
5.3.6 Roche Erythropoietin Sales by Application in 2024
5.3.7 Roche Erythropoietin Sales by Geographic Area in 2024
5.3.8 Roche Recent Developments
5.4 Galenica
5.4.1 Galenica Company Information
5.4.2 Galenica Description, Business Overview
5.4.3 Galenica Erythropoietin Products Offered
5.4.4 Galenica Erythropoietin Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Galenica Erythropoietin Sales by Product in 2024
5.4.6 Galenica Erythropoietin Sales by Application in 2024
5.4.7 Galenica Erythropoietin Sales by Geographic Area in 2024
5.4.8 Galenica Recent Developments
5.5 Emcure
5.5.1 Emcure Company Information
5.5.2 Emcure Description, Business Overview
5.5.3 Emcure Erythropoietin Products Offered
5.5.4 Emcure Erythropoietin Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Emcure Erythropoietin Sales by Product in 2024
5.5.6 Emcure Erythropoietin Sales by Application in 2024
5.5.7 Emcure Erythropoietin Sales by Geographic Area in 2024
5.5.8 Emcure Recent Developments
5.6 Kyowa Hakko Kirin
5.6.1 Kyowa Hakko Kirin Company Information
5.6.2 Kyowa Hakko Kirin Description, Business Overview
5.6.3 Kyowa Hakko Kirin Erythropoietin Products Offered
5.6.4 Kyowa Hakko Kirin Erythropoietin Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Kyowa Hakko Kirin Erythropoietin Sales by Product in 2024
5.6.6 Kyowa Hakko Kirin Erythropoietin Sales by Application in 2024
5.6.7 Kyowa Hakko Kirin Erythropoietin Sales by Geographic Area in 2024
5.6.8 Kyowa Hakko Kirin Recent Developments
5.7 3SBio
5.7.1 3SBio Company Information
5.7.2 3SBio Description, Business Overview
5.7.3 3SBio Erythropoietin Products Offered
5.7.4 3SBio Erythropoietin Sales, Revenue and Gross Margin (2020-2025)
5.7.5 3SBio Erythropoietin Sales by Product in 2024
5.7.6 3SBio Erythropoietin Sales by Application in 2024
5.7.7 3SBio Erythropoietin Sales by Geographic Area in 2024
5.7.8 3SBio Recent Developments
5.8 Biocon
5.8.1 Biocon Company Information
5.8.2 Biocon Description, Business Overview
5.8.3 Biocon Erythropoietin Products Offered
5.8.4 Biocon Erythropoietin Sales, Revenue and Gross Margin (2020-2025)
5.8.5 Biocon Erythropoietin Sales by Product in 2024
5.8.6 Biocon Erythropoietin Sales by Application in 2024
5.8.7 Biocon Erythropoietin Sales by Geographic Area in 2024
5.8.8 Biocon Recent Developments
5.9 LG Life Sciences
5.9.1 LG Life Sciences Company Information
5.9.2 LG Life Sciences Description, Business Overview
5.9.3 LG Life Sciences Erythropoietin Products Offered
5.9.4 LG Life Sciences Erythropoietin Sales, Revenue and Gross Margin (2020-2025)
5.9.5 LG Life Sciences Erythropoietin Sales by Product in 2024
5.9.6 LG Life Sciences Erythropoietin Sales by Application in 2024
5.9.7 LG Life Sciences Erythropoietin Sales by Geographic Area in 2024
5.9.8 LG Life Sciences Recent Developments
6 North America
6.1 North America Erythropoietin Market Size YoY Growth 2020-2031
6.2 North America Erythropoietin Market Facts & Figures by Country
6.2.1 North America Erythropoietin Sales by Country (2020-2031)
6.2.2 North America Erythropoietin Revenue by Country (2020-2031)
6.3 North America Erythropoietin Sales by Type (2020-2025)
6.4 North America Erythropoietin Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Erythropoietin Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Erythropoietin Market Facts & Figures by Region
7.2.1 Asia-Pacific Erythropoietin Sales by Region (2020-2031)
7.2.2 Asia-Pacific Erythropoietin Revenue by Region (2020-2031)
7.3 Asia-Pacific Erythropoietin Sales by Type (2020-2025)
7.4 Asia-Pacific Erythropoietin Sales by Application (2020-2025)
8 Europe
8.1 Europe Erythropoietin Market Size YoY Growth 2020-2031
8.2 Europe Erythropoietin Market Facts & Figures by Country
8.2.1 Europe Erythropoietin Sales by Country (2020-2031)
8.2.2 Europe Erythropoietin Revenue by Country (2020-2031)
8.3 Europe Erythropoietin Sales by Type (2020-2025)
8.4 Europe Erythropoietin Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Erythropoietin Market Size YoY Growth 2020-2031
9.2 Latin America Erythropoietin Market Facts & Figures by Country
9.2.1 Latin America Erythropoietin Sales by Country (2020-2031)
9.2.2 Latin America Erythropoietin Revenue by Country (2020-2031)
9.3 Latin America Erythropoietin Sales by Type (2020-2025)
9.4 Latin America Erythropoietin Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Erythropoietin Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Erythropoietin Market Facts & Figures by Country
10.2.1 Middle East and Africa Erythropoietin Sales by Country (2020-2031)
10.2.2 Middle East and Africa Erythropoietin Revenue by Country (2020-2031)
10.3 Middle East and Africa Erythropoietin Sales by Type (2020-2025)
10.4 Middle East and Africa Erythropoietin Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Erythropoietin Supply Chain Analysis
11.2 Erythropoietin Key Raw Materials and Upstream Suppliers
11.3 Erythropoietin Clients Analysis
11.4 Erythropoietin Sales Channel and Sales Model Analysis
11.4.1 Erythropoietin Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Erythropoietin Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Erythropoietin Distributors
12 Erythropoietin Market Dynamics
12.1 Erythropoietin Industry Trends
12.2 Erythropoietin Market Drivers
12.3 Erythropoietin Market Challenges
12.4 Erythropoietin Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
FEATURED COMPANIES
Amgen Inc
Johnson & Johnson
Roche
Galenica Ltd
Emcure
Kyowa Hakko Kirin
3SBio Inc
Biocon Ltd.
LG Life Sciences
List of Tables
 Table 1. Global Erythropoietin Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Global Erythropoietin Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 3. Global Erythropoietin Market Size by Region (US$ Million): 2024 VS 2031
 Table 4. Global Erythropoietin Sales by Region (2020-2025) & (K Units)
 Table 5. Global Erythropoietin Sales Forecast by Region (2026-2031) & (K Units)
 Table 6. Global Erythropoietin Revenue by Region (2020-2025) & (US$ Million)
 Table 7. Global Erythropoietin Revenue Forecast by Region (2026-2031) & (US$ Million)
 Table 8. Global Erythropoietin Sales Volume by Type (2020-2025) & (K Units)
 Table 9. Global Erythropoietin Sales Volume by Type (2026-2031) & (K Units)
 Table 10. Global Erythropoietin Revenue by Type (2020-2025) & (US$ Million)
 Table 11. Global Erythropoietin Revenue Forecast by Type (2026-2031) & (US$ Million)
 Table 12. Global Erythropoietin Sales Volume by Application (2020-2025) & (K Units)
 Table 13. Global Erythropoietin Sales Volume by Application (2026-2031) & (K Units)
 Table 14. Global Erythropoietin Revenue by Application (2020-2025) & (US$ Million)
 Table 15. Global Erythropoietin Revenue by Application (2026-2031) & (US$ Million)
 Table 16. Global Erythropoietin Sales by Manufacturer (2020-2025) & (K Units)
 Table 17. Global Erythropoietin Sales Share by Manufacturer (2020-2025)
 Table 18. Erythropoietin Revenue by Manufacturer (2020-2025) & (US$ Million)
 Table 19. Erythropoietin Revenue Share by Manufacturer (2020-2025)
 Table 20. Key Manufacturers Erythropoietin Price (2020-2025) & (USD/Unit)
 Table 21. Ranking of Global Top Erythropoietin Manufacturers by Revenue (US$ Million) in 2024
 Table 22. Global Erythropoietin Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
 Table 23. Global Erythropoietin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Erythropoietin as of 2024)
 Table 24. Erythropoietin Manufacturers Manufacturing Base Distribution and Headquarters
 Table 25. Date of International Manufacturers Enter into Erythropoietin Market
 Table 26. Manufacturers Erythropoietin Product Type and Application
 Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 28. Amgen Company Information
 Table 29. Amgen Description and Business Overview
 Table 30. Amgen Erythropoietin Product
 Table 31. Amgen Erythropoietin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 32. Amgen Sales Proportion of Erythropoietin by Product in 2024
 Table 33. Amgen Sales Proportion of Erythropoietin by Application in 2024
 Table 34. Amgen Sales Proportion of Erythropoietin by Geographic Area in 2024
 Table 35. Amgen Recent Developments
 Table 36. Johnson & Johnson Company Information
 Table 37. Johnson & Johnson Description and Business Overview
 Table 38. Johnson & Johnson Erythropoietin Product
 Table 39. Johnson & Johnson Erythropoietin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 40. Johnson & Johnson Sales Proportion of Erythropoietin by Product in 2024
 Table 41. Johnson & Johnson Sales Proportion of Erythropoietin by Application in 2024
 Table 42. Johnson & Johnson Sales Proportion of Erythropoietin by Geographic Area in 2024
 Table 43. Johnson & Johnson Recent Developments
 Table 44. Roche Company Information
 Table 45. Roche Description and Business Overview
 Table 46. Roche Erythropoietin Product
 Table 47. Roche Erythropoietin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 48. Roche Sales Proportion of Erythropoietin by Product in 2024
 Table 49. Roche Sales Proportion of Erythropoietin by Application in 2024
 Table 50. Roche Sales Proportion of Erythropoietin by Geographic Area in 2024
 Table 51. Roche Recent Developments
 Table 52. Galenica Company Information
 Table 53. Galenica Description and Business Overview
 Table 54. Galenica Erythropoietin Product
 Table 55. Galenica Erythropoietin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 56. Galenica Sales Proportion of Erythropoietin by Product in 2024
 Table 57. Galenica Sales Proportion of Erythropoietin by Application in 2024
 Table 58. Galenica Sales Proportion of Erythropoietin by Geographic Area in 2024
 Table 59. Galenica Recent Developments
 Table 60. Emcure Company Information
 Table 61. Emcure Description and Business Overview
 Table 62. Emcure Erythropoietin Product
 Table 63. Emcure Erythropoietin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 64. Emcure Sales Proportion of Erythropoietin by Product in 2024
 Table 65. Emcure Sales Proportion of Erythropoietin by Application in 2024
 Table 66. Emcure Sales Proportion of Erythropoietin by Geographic Area in 2024
 Table 67. Emcure Recent Developments
 Table 68. Kyowa Hakko Kirin Company Information
 Table 69. Kyowa Hakko Kirin Description and Business Overview
 Table 70. Kyowa Hakko Kirin Erythropoietin Product
 Table 71. Kyowa Hakko Kirin Erythropoietin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 72. Kyowa Hakko Kirin Sales Proportion of Erythropoietin by Product in 2024
 Table 73. Kyowa Hakko Kirin Sales Proportion of Erythropoietin by Application in 2024
 Table 74. Kyowa Hakko Kirin Sales Proportion of Erythropoietin by Geographic Area in 2024
 Table 75. Kyowa Hakko Kirin Recent Developments
 Table 76. 3SBio Company Information
 Table 77. 3SBio Description and Business Overview
 Table 78. 3SBio Erythropoietin Product
 Table 79. 3SBio Erythropoietin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 80. 3SBio Sales Proportion of Erythropoietin by Product in 2024
 Table 81. 3SBio Sales Proportion of Erythropoietin by Application in 2024
 Table 82. 3SBio Sales Proportion of Erythropoietin by Geographic Area in 2024
 Table 83. 3SBio Recent Developments
 Table 84. Biocon Company Information
 Table 85. Biocon Description and Business Overview
 Table 86. Biocon Erythropoietin Product
 Table 87. Biocon Erythropoietin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Biocon Sales Proportion of Erythropoietin by Product in 2024
 Table 89. Biocon Sales Proportion of Erythropoietin by Application in 2024
 Table 90. Biocon Sales Proportion of Erythropoietin by Geographic Area in 2024
 Table 91. Biocon Recent Developments
 Table 92. LG Life Sciences Company Information
 Table 93. LG Life Sciences Description and Business Overview
 Table 94. LG Life Sciences Erythropoietin Product
 Table 95. LG Life Sciences Erythropoietin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 96. LG Life Sciences Sales Proportion of Erythropoietin by Product in 2024
 Table 97. LG Life Sciences Sales Proportion of Erythropoietin by Application in 2024
 Table 98. LG Life Sciences Sales Proportion of Erythropoietin by Geographic Area in 2024
 Table 99. LG Life Sciences Recent Developments
 Table 100. North America Erythropoietin Sales by Country (2020-2025) & (K Units)
 Table 101. North America Erythropoietin Sales by Country (2026-2031) & (K Units)
 Table 102. North America Erythropoietin Revenue by Country (2020-2025) & (US$ Million)
 Table 103. North America Erythropoietin Revenue by Country (2026-2031) & (US$ Million)
 Table 104. North America Erythropoietin Sales by Type (2020-2025) & (K Units)
 Table 105. North America Erythropoietin Sales by Application (2020-2025) & (K Units)
 Table 106. Asia-Pacific Erythropoietin Sales by Region (2020-2025) & (K Units)
 Table 107. Asia-Pacific Erythropoietin Sales by Region (2026-2031) & (K Units)
 Table 108. Asia-Pacific Erythropoietin Revenue by Region (2020-2025) & (US$ Million)
 Table 109. Asia-Pacific Erythropoietin Revenue by Region (2026-2031) & (US$ Million)
 Table 110. Asia-Pacific Erythropoietin Sales by Type (2020-2025) & (K Units)
 Table 111. Asia-Pacific Erythropoietin Sales by Application (2020-2025) & (K Units)
 Table 112. Europe Erythropoietin Sales by Country (2020-2025) & (K Units)
 Table 113. Europe Erythropoietin Sales by Country (2026-2031) & (K Units)
 Table 114. Europe Erythropoietin Revenue by Country (2020-2025) & (US$ Million)
 Table 115. Europe Erythropoietin Revenue by Country (2026-2031) & (US$ Million)
 Table 116. Europe Erythropoietin Sales by Type (2020-2025) & (K Units)
 Table 117. Europe Erythropoietin Sales by Application (2020-2025) & (K Units)
 Table 118. Latin America Erythropoietin Sales by Country (2020-2025) & (K Units)
 Table 119. Latin America Erythropoietin Sales by Country (2026-2031) & (K Units)
 Table 120. Latin America Erythropoietin Revenue by Country (2020-2025) & (US$ Million)
 Table 121. Latin America Erythropoietin Revenue by Country (2026-2031) & (US$ Million)
 Table 122. Latin America Erythropoietin Sales by Type (2020-2025) & (K Units)
 Table 123. Latin America Erythropoietin Sales by Application (2020-2025) & (K Units)
 Table 124. Middle East and Africa Erythropoietin Sales by Country (2020-2025) & (K Units)
 Table 125. Middle East and Africa Erythropoietin Sales by Country (2026-2031) & (K Units)
 Table 126. Middle East and Africa Erythropoietin Revenue by Country (2020-2025) & (US$ Million)
 Table 127. Middle East and Africa Erythropoietin Revenue by Country (2026-2031) & (US$ Million)
 Table 128. Middle East and Africa Erythropoietin Sales by Type (2020-2025) & (K Units)
 Table 129. Middle East and Africa Erythropoietin Sales by Application (2020-2025) & (K Units)
 Table 130. Erythropoietin Key Raw Materials, Industry Status and Trend
 Table 131. Erythropoietin Key Raw Materials and Upstream Suppliers
 Table 132. Erythropoietin Clients Status and Trend
 Table 133. Erythropoietin Typical Clients
 Table 134. Erythropoietin Distributors
 Table 135. Erythropoietin Market Trends
 Table 136. Erythropoietin Market Drivers
 Table 137. Erythropoietin Market Challenges
 Table 138. Erythropoietin Market Restraints
 Table 139. Research Programs/Design for This Report
 Table 140. Key Data Information from Secondary Sources
 Table 141. Key Data Information from Primary Sources
 Table 142. QYR Business Unit and Senior & Team Lead Analysts


List of Figures
 Figure 1. Erythropoietin Product Picture
 Figure 2. Global Erythropoietin Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
 Figure 3. Global Erythropoietin Sales Market Share by Type in 2024 & 2031
 Figure 4. Epoetin-alfa Product Picture
 Figure 5. Epoetin-beta Product Picture
 Figure 6. Darbepoetin-alfa Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global Erythropoietin Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
 Figure 9. Global Erythropoietin Sales Market Share by Application in 2024 & 2031
 Figure 10. Anemia
 Figure 11. Kidney Disorders
 Figure 12. Others
 Figure 13. Erythropoietin Report Years Considered
 Figure 14. Global Erythropoietin Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Erythropoietin Market Size 2020-2031 (US$ Million)
 Figure 16. Global Erythropoietin Sales 2020-2031 (K Units)
 Figure 17. Global Erythropoietin Sales Market Share Forecast by Region (2020-2031)
 Figure 18. Global Erythropoietin Revenue Market Share by Region (2020-2031)
 Figure 19. Global Erythropoietin Sales Market Share Forecast by Type (2020-2031)
 Figure 20. Global Erythropoietin Revenue Market Share Forecast by Type (2020-2031)
 Figure 21. Erythropoietin Average Selling Price (ASP) by Type (2020-2025) & (USD/Unit)
 Figure 22. Global Erythropoietin Sales Market Share Forecast by Application (2020-2031)
 Figure 23. Global Erythropoietin Revenue Market Share Forecast by Application (2020-2031)
 Figure 24. Erythropoietin Average Selling Price (ASP) by Application (2020-2025) & (USD/Unit)
 Figure 25. Epoetin-alfa of Erythropoietin Revenue Market Share by Application, 2024 VS 2031
 Figure 26. Epoetin-beta of Erythropoietin Revenue Market Share by Application, 2024 VS 2031
 Figure 27. Darbepoetin-alfa of Erythropoietin Revenue Market Share by Application, 2024 VS 2031
 Figure 28. Others of Erythropoietin Revenue Market Share by Application, 2024 VS 2031
 Figure 29. Global Erythropoietin Sales Share by Manufacturer in 2024
 Figure 30. Erythropoietin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 31. Epoetin-alfa Market Sales Proportion by Manufacturer in 2024
 Figure 32. Epoetin-beta Market Sales Proportion by Manufacturer in 2024
 Figure 33. Darbepoetin-alfa Market Sales Proportion by Manufacturer in 2024
 Figure 34. Others Market Sales Proportion by Manufacturer in 2024
 Figure 35. North America Erythropoietin Revenue 2020-2031 (US$ Million)
 Figure 36. North America Erythropoietin Sales Market Share by Type (2020-2025)
 Figure 37. North America Erythropoietin Sales Market Share by Application (2020-2025)
 Figure 38. Asia-Pacific Erythropoietin Revenue 2020-2031 (US$ Million)
 Figure 39. Asia-Pacific Erythropoietin Sales Market Share by Region (2020-2031)
 Figure 40. Asia-Pacific Erythropoietin Revenue Market Share by Region (2020-2031)
 Figure 41. Asia-Pacific Erythropoietin Sales Market Share by Type (2020-2025)
 Figure 42. Asia-Pacific Erythropoietin Sales Market Share by Application (2020-2025)
 Figure 43. Europe Erythropoietin Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 44. Europe Erythropoietin Sales Market Share by Country (2020-2031)
 Figure 45. Europe Erythropoietin Revenue Market Share by Country (2020-2031)
 Figure 46. Europe Erythropoietin Sales Market Share by Type (2020-2025)
 Figure 47. Europe Erythropoietin Sales Market Share by Application (2020-2025)
 Figure 48. Latin America Erythropoietin Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 49. Latin America Erythropoietin Sales Market Share by Country (2020-2031)
 Figure 50. Latin America Erythropoietin Revenue Market Share by Country (2020-2025)
 Figure 51. Latin America Erythropoietin Sales Market Share by Type (2020-2025)
 Figure 52. Latin America Erythropoietin Sales Market Share by Application (2020-2025)
 Figure 53. Middle East and Africa Erythropoietin Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 54. Middle East and Africa Erythropoietin Sales Market Share by Country (2020-2031)
 Figure 55. Middle East and Africa Erythropoietin Revenue Market Share by Country (2020-2031)
 Figure 56. Middle East and Africa Erythropoietin Sales Market Share by Type (2020-2025)
 Figure 57. Middle East and Africa Erythropoietin Sales Market Share by Application (2020-2025)
 Figure 58. Erythropoietin Supply Chain (Upstream and Downstream Market)
 Figure 59. Global Production Market Share of Erythropoietin Raw Materials by Region in 2024
 Figure 60. Erythropoietin Distribution Channels
 Figure 61. Global Erythropoietin Percentage 2020-2031: Indirect Sales VS Direct Sales
 Figure 62. Global Erythropoietin Percentage 2020-2031: Online Sales VS Offline Sales
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5900

This license allows only one user to access the PDF.
Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Global Recombinant Erythropoietin Drugs Market Insights Forecast to 2030
Global Short acting EPO Drugs Market Research Report 2024
Global Short acting Recombinant Human Erythropoietin Market Research Report 2024
Global Short acting Recombinant Human Erythropoietin Drugs Market Research Report 2024
Global Recombinant Human Erythropoietin for Injection Market Research Report 2024
Global Medical Erythropoietin Injection Market Research Report 2024
Global Medical Human Erythropoietin Injection Market Research Report 2024
Global Erythropoietin Drugs Market Research Report 2024
Global Short acting Recombinant Human Erythropoietin Injections Market Research Report 2024
Erythropoietin EPO Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Erythropoietin EPO Treatment Market Research Report 2024
Erythropoietin Biosimilar Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Erythropoietin ELISA Test Kit Market Research Report 2024
Global Long acting Recombinant Human Erythropoietin Market Research Report 2024
Global Long acting Recombinant Human Erythropoietin Drugs Market Research Report 2024
Global Long acting Recombinant Human Erythropoietin Injections Market Research Report 2024
Global Long acting EPO Drugs Market Research Report 2024
Global Erythropoietin Stimulating Agents Market Insights Forecast to 2030
Renal Anemia Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Recombinant Human Erythropoietin Injection Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions